Pharmalink AB has announced that it has gained an exclusive global license to Archimedes Pharma Ltd.’s TARGIT® drug delivery technology for use in its lead program, Nefecon® for the treatment of the ...
BOSTON--(BUSINESS WIRE)--TARGIT, the company behind market-leading business intelligence (BI) and analytics platform TARGIT Decision Suite, today signed an agreement with GRO Capital, acquiring all ...
LONDON, June 26, 2025 /PRNewswire-PRWeb/ -- Forterro has entered into a binding agreement to acquire TARGIT, a Denmark-headquartered business intelligence (BI) and analytics software company that ...
Pharmalink AB, today announces it has gained an exclusive global license to Archimedes Pharma Ltd.'s TARGIT® drug delivery technology for use in its lead program, Nefecon® for the treatment of the ...